Shionogi & Co Ltd (SGIOF) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, time to start today's meeting. I am Kyokawa, the head of Public Relations Department at Shio Nuki & Company. Thank you very much for taking time to join us today. We will now begin the CEO Nogi and Company Limited's second quarter financial results briefing for fiscal year 2024. First of all, let me introduce the speakers for today. This is Isao Teshiyogi, Chairman, President, and CEO. And next, Mr. John Keller, Senior Vice President, R&D Supervisory Unit. Very nice to see you. Next, Mr. Toshinobu Iwasaki, Senior Vice President, Healthcare Business Unit. I am Iwasaki. Very nice to see you. And then next, Mr. Goji Hanazaki, Senior Vice President, Supply Supervisory Unit, Global Business Division. Very nice to see you. Next, Mr. Takeki Uehara, Senior Vice President, Drug Development and Regulatory Science Division. Nice to see you. Lastly, Ms. Masako Kuro, Vice President, Finance and Accounting Department. Today, we'll begin with the overview of the financial result, followed by the presentation of initiatives for achieving 2030 vision given by Mr. Teshioki, Mr. John Keller, Mr. Uehara, and Mr. Iwasaki in this order. We will then take questions from the floor. The event will end at 16.30. Simultaneous interpretation is available for today. If you use the simultaneous interpretation, please select either Japanese or English from the globe icon at the bottom of the screen. So let's get started. President Shioge, you have a floor, please. Well, at 1,500, we open the floor, and the result of a PEP test will be given. So very nice to see you. Well, the figures, I guess, is well understood by you. So let me go to the page four. So, well, the point of our company is that the core of 100 billion purchased by the government and also the one-time payment of...